protein intake and glp 1 GLP-1 weight loss drugs leave users low on key nutrients, study finds Whether you're taking a GLP-1
Description
95% CI: 0.581.14)
This is clearly established in the FDA drug l...
The approval could expand access to an effective therapy for managing obesity.
Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.
#PharmaBD #PharmaStrategy #GLP1 #Obesity #PharmaDeals #DrugDevelopment #Pfizer
Today, its a frequent topic of conversation and media coverage
